Cell line · CVCL_0013
MOLT-4
Cancer cell line, Homo sapiens. Adult T acute lymphoblastic leukemia. 107 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. MOLT-4. Cell lines, record CVCL_0013. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0013
On this page
Cell line
As Cellosaurus gives it.
- Name
- MOLT-4
- Accession
- CVCL_0013
- RRID
- RRID:CVCL_0013
- Synonyms
- Molt-4, MOLT 4, Molt 4, MOLT.4, MOLT4, Molt4, GM02219, GM02219C, GM2219C, GM02219D
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 19Y
- Category
- Cancer cell line
- Diseases
- Adult T acute lymphoblastic leukemia (NCIt C9142); Precursor T-cell acute lymphoblastic leukemia (ORDO Orphanet_99861)
- Derived from
- Peripheral blood (in situ)
- Cell type
- T-cell
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers107
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Multi-omics-driven personalized management of advanced HCC. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Impact of IL-21 on CAR T-cell manufacturing: phenotypic, metabolic, and functional outcomes. | Front Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Dynamic Switching of Apoptosis-Modulating Bim Heterodimers in Response to BH3 Mimetics in Xenograft Models of Hematologic Malignancies. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Dual regulation of CXCR6+CD8+ T cells modulates cytotoxic and exhaustion-associated programs during prostate cancer progression. | J Immunother Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting Menin in T-lineage Acute Lymphoblastic Leukemia. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| IMPDH inhibition enhances cytarabine efficacy in SAMHD1-expressing leukaemia cells via guanine nucleotide depletion. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Discovery of SKP2-Recruiting PROTACs for Target Protein Degradation. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Distinct Regulation of the ARF and TAp73 Tumor Suppressor Genes by the Transcription Factor E2F1 Enables Discrimination of Cancer Cells from Normal Growing Cells. | Cells | 2026 | Its Methods give the RRID and name the line | PubMed | |
| HIV-1 establishes immediate latency in T cells expressing the viral Nef protein. | FEBS Open Bio | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 107
See all 107 papersRelatives13
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | A4H12 | CVCL_A6KJ | Cell lines | |
| Derived from it | M311 [Human leukemia] | CVCL_M771 | Cell lines | |
| Derived from it | MOLT-4 Ma | CVCL_E8AS | Cell lines | |
| Derived from it | MOLT-4 clone 8 | CVCL_F827 | Cell lines | |
| Derived from it | MOLT-4(Cas9) | CVCL_E7JC | Cell lines | |
| Derived from it | MOLT-4-luc2 | CVCL_5J16 | Cell lines | |
| Derived from it | MOLT-4/ADR | CVCL_4Y72 | Cell lines | |
| Derived from it | MOLT-4/R7hyg | CVCL_E3D7 | Cell lines | |
| Derived from it | MOLT-4F | CVCL_2792 | Cell lines | |
| Derived from it | MOLT-4V | CVCL_F830 | Cell lines |
1 to 10 of 13
See all 13 relativesCell banks19
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0013
GET https://conductscience.org/api/cell-lines/v1/CVCL_0013/papers?page=2